Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number** · Amount** · capital** · loss · deficit · equity |
|---|
| Balance as of January 1, 2024 | 452,724 | | 1 | 65,386 | (771) | (59,881) | 4,735 |
|---|
| Stock-based compensation related to options granted to employees and consultants | 80,000 | | -* | 306 | - | - | 306 |
|---|
| Issuance of shares for sellers post Business Combination | 4,360 | | -* | 3 | - | - | 3 |
|---|
| Effect of reverse stock split | 74,683 | | -* | - | - | - | - |
|---|
| Issuance of shares, net of issuance cost of $442 (***) | 79,000 | | -* | 2,819 | - | - | 2,819 |
|---|
| Exercise of shares in abeyance | 478,364 | **** | -* | - | - | - | - |
|---|
| Total comprehensive loss | - | | - | - | (125) | (3,280) | (3,405) |
|---|
| Balance as of September 30, 2024 | 1,169,131 | | 1 | 68,514 | (896) | (63,161) | 4,458 |
|---|
| (*) | Represents an amount less than $1. |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split effected in April 2024, see note 8 (d). |
|---|
| (***) | See note 8 (f). |
|---|
| (****) | 104,375 shares relates to the August 2023 inducement letter deal - see note 13 (d) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. |
|---|
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number | Amount | capital | loss | deficit | equity |
|---|
| Balance as of January 1, 2023 | 183,015 | 1 | 58,673 | (637) | (53,501) | 4,536 |
|---|
| Stock-based compensation related to options granted to employees and consultants | (1,000) | -* | 290 | - | - | 290 |
|---|
| Issuance of shares, net of issuance cost of $959 (**) | 54,000 | -* | 6,258 | - | - | 6,258 |
|---|
| Exercise of warrants and prefunded warrants | 136,710 | -* | - | - | - | - |
|---|
| Total comprehensive loss | - | - | - | (75) | (5,077) | (5,152) |
|---|
| Balance as of September 30, 2023 | 372,725 | 1 | 65,221 | (712) | (58,578) | 5,932 |
|---|
| (*) | Represents an amount less than $1 |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split effected in April 2024, see note 8 (d). |
|---|
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number** | Amount** | Capital** | loss | deficit | equity |
|---|
| Balance as of July 1, 2024 | 883,131 | 1 | 68,425 | (870) | (61,861) | 5,695 |
|---|
| Stock-based compensation related to options granted to employees and consultants | - | - | 89 | - | - | 89 |
|---|
| Exercise of shares in abeyance | 286,000 | -* | - | - | - | - |
|---|
| Total comprehensive loss | - | - | - | (26) | (1,300) | (1,326) |
|---|
| Balance as of September 30, 2024 | 1,169,131 | 1 | 68,514 | (896) | (63,161) | 4,458 |
|---|
| (*) | Represents an amount less than $1 |
|---|
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number | Amount | capital | loss | deficit | equity |
|---|
| Balance as of July 1, 2023 | 304,848 | 1 | 61,554 | (676) | (57,446) | 3,433 |
|---|
| Stock-based compensation related to options granted to employees and consultants | - | - | 68 | - | - | 68 |
|---|
| Issuance of shares, net of issuance cost of $518 | 33,750 | -* | 3,599 | - | - | 3,599 |
|---|
| Exercise of prefunded warrants | 34,127 | -* | - | - | - | - |
|---|
| Total comprehensive loss | - | - | - | (36) | (1,132) | (1,168) |
|---|
| Balance as of September 30, 2023 | 372,725 | 1 | 65,221 | (712) | (58,578) | 5,932 |
|---|
| (*) | Represents an amount less than $1 |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split effected in April 2024, see note 8 (d). |
|---|
